IMPAX Laboratories, Inc. Acquires Rights to Abbreviated New Drug Applications From Watson Laboratories, Inc. And Cobalt Laboratories

December 2, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced it acquired Abbreviated New Drug Applications (ANDA) from Watson Pharmaceuticals and Cobalt Laboratories, a subsidiary of Arrow Group.

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions Regulatory